Abstract
Retinoblastoma binding protein 6 (RBBP6) is a nuclear protein, previously implicated in the regulation of cell cycle and apoptosis. The human RBBP6 gene codes for three protein isoforms and isoform 3 consists of the domain with no name domain only whilst the other two isoforms, 1 and 2 comprise of additional zinc, RING, retinoblastoma and p53 binding domains. In this study, the localization of RBBP6 using RBBP6 variant 3 mRNA-specific probe was performed to investigate the expression levels of the gene in different tumours and find a link between RBBP6 and human carcinogenesis. Using FISH, real-time PCR and Western blotting analysis our results show that RBBP6 isoform 3 is down-regulated in human cancers. RBBP6 isoform 3 knock-down resulted in reduced G2/M cell cycle arrest whilst its over-expression resulted in increased G2/M cell cycle arrest using propidium iodide DNA staining. The results further demonstrate that the RBBP6 isoform 3 may be the cell cycle regulator and involved in mitotic apoptosis not the isoform 1 as previously reported for mice. In conclusion, these findings suggest that RBBP6 isoform 3 is a cell cycle regulator and may be de-regulated in carcinogenesis.
Similar content being viewed by others
References
Sakai Y, Saijom M, Coelho K, Kishino T, Niikawa N, Taya Y (1995) cDNA sequence and chromosomal localization of a novel human protein, RBQ-1 (RBBP6), that binds to the retinoblastoma gene product. Genomics 30:98–101
Gao S, Scott R (2002) P2P-R protein overexpression restricts mitotic progression at prometaphase and promotes mitotic apoptosis. J Cell Physiol 193:199–207
Gao S, Witte M, Scott R (2002) P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity. J Cell Physiol 191:145–154
Witte M, Scott R (1997) The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. Proc Natl Acad Sci USA 94:1212–1217
Simons A, Melamed-Bessudo C, Wolkowicz R, Sperling J, Sperling R, Eisenbach L, Rotter V (1997) PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb. Oncogene 14:145–155
Pugh D, Ab E, Faro A, Lutya PT, Hoffmann E, Rees DJ (2006) DWNN, a novel ubiquitin-like domain, implicates RBBP 6 in mRNA processing and ubiquitin-like pathways. BMC Struct Biol 6:1
George A (1995) A new method for isolating genes involved in the processing and presentation of antigens to cytotoxic T cells. D Phil Thesis, University of Oxford
Pretorius A (2007) Functional analysis of the mouse RBBP6 gene using interference RNA. PhD Thesis, University of the Western Cape
Gao S, Scott R (2003) Stable overexpression of specific segments of the P2P-R protein in human MCF-7 cells promotes camptothecin-induced apoptosis. J Cell Physiol 197:445–452
Chibi M, Meyer M, Skepu A, Rees DJG, Moolman-Smoock JC, Pugh DJ (2008) RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1. J Mol Biol 384:908–916
Bellstedt D, Human P, Rowland GF, Van der Merve KJ (1987) Acid-treated, naked bacteria as immune carriers for protein antigens. J Immunol Methods 98:249–255
Meyer M, Essack M, Kanyanda S, Rees J (2008) A low-cost flow cytometric assay for the detection and quantification of apoptosis using an anionic halogenated fluorescein dye. Biotechniques 45:317–320
Yoshitake Y, Nakatsura T, Monji M, Senju S, Matsuyoshi H, Tsukamoto H, Hosaka S, Komori H, Fukuma D, Ikuta Y, Katagiri T, Furukawa Y, Ito H, Shinohara M, Nakamura Y, Nishimura Y (2004) Proliferation potential-related protein, an ideal oesophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis. Clin Cancer Res 10:6437–6448
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and \( 2^{- \Updelta \Updelta {C_{{\text{T}}}}} \) method. Methods 25:402–408
Yu Y, Yip G, Tan P, Thike AA, Matsumoto K, Tsujimoto M, Bay BH (2010) Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol 37:483–492
Basaki Y, Taguchi K, Izumi H, Murakami Y, Kubo T, Hosoi F, Watari K, Nakano K, Kawaguchi H, Ohno S, Kohno K, Ono M, Kuwano M (2010) Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. Eur J Cancer 46:954–965
Takahashi M, Shimajiri S, Izumi H, Hirano G, Kashiwagi E, Yasuniwa Y, Wu Y, Han B, Akiyama M, Nishizawa S, Sasaguri Y, Kohno K (2010) Y-box binding protein-1 is a novel molecular target for tumour vessels. Cancer Sci 101:1367–1373
Mather A, Rakgotho M, Ntwasa M (2005) SNAMA, a novel protein with a DWNN domain and a RING finger-like motif: a possible role in apoptosis. Biochim Biophys Acta 1727:169–176
Peidis P, Giannakouros T, Burow M, Williams RW, Scott RE (2010) Systems genetics analyses predict a transcription role for P2P-R: molecular confirmation that P2P-R is a transcriptional co-repressor. BMC Syst Biol 4:14
Tai H, Kubota N, Kato S (2000) Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells. Biochem Biophys Res Commun 267:311–316
Ku T, Crowe D (2007) Coactivator-mediated estrogen response in human squamous cell carcinoma lines. J Endocrinol 193:147–155
Hudelist G, Czerwenka K, Kubista E, Marton E, Pischinger K, Singer CF (2003) Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator. Breast Cancer Res Treat 78:193–204
Ramaswamy B, Majumolers S, Roy S, Ghoshal K, Kutay H, Datta J, Younes M, Shapiro CL, Motiwala T, Jacob ST (2009) Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity. Mol Endocrinol 23:176–187
Mbita Z (2004) Molecular analysis of a novel death-related gene, domain with no name (DWNN), in human parenchymal diseases. MSc Thesis, University of the Witwatersrand
Kirkin V, Dikic I (2007) Role of ubiquitin- and Ubl-binding proteins in cell signalling. Curr Opin Cell Biol 19:199–205
Liao S, Wang T, Fan K, Tu X (2010) The small ubiquitin-like modifier (SUMO) is essential in cell cycle regulation in Trypanosoma brucei. Exp Cell Res 316:704–715
Piñol-Roma S, Dreyfuss G (1993) hnRNP proteins: localization and transport between the nucleus and the cytoplasm. Trends Cell Biol 3:151–155
Vo L, Minet M, Schmitter JM, Lacroute F, Wyers F (2001) Mpe1, a zinc knuckle protein, is an essential component of yeast cleavage and polyadenylation factor required for the cleavage and polyadenylation of mRNA. Mol Cell Biol 21:8346–8356
Li L, Deng L, Xing G, Teng Y, Tian C, Cheng X, Yin X, Yang J, Gao X, Zhu Y, Sun Q, Zhang L, Yang X, He F (2007) PACT is a negative regulator of p53 and essential for cell growth and embryonic development. Proc Natl Acad Sci USA 104:7951–7956
Scott R, Giannakouros T, Gao S, Peidis P (2003) Functional potential of P2P-R: a role in the cell cycle and cell differentiation related to its interactions with proteins that bind to matrix associated regions of DNA? J Cell Biochem 90:6–12
Scott R, Gao S (2002) P2P-R deficiency modifies nocodazole-induced mitotic arrest and UV-induced apoptosis. Anticancer Res 22:3837–3842
Motadi LR, Bhoola KD, Dlamini Z (2011) Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer. Immunology 216:1065–1073
Acknowledgments
We are grateful to the National Research Foundation (South Africa), the Council for Scientific and Industrial Research (CSIR) and the University of the Witwatersrand for funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mbita, Z., Meyer, M., Skepu, A. et al. De-regulation of the RBBP6 isoform 3/DWNN in human cancers. Mol Cell Biochem 362, 249–262 (2012). https://doi.org/10.1007/s11010-011-1150-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1150-5